Cytek Biosciences Correlations

CTKB Stock  USD 5.00  0.01  0.20%   
The current 90-days correlation between Cytek Biosciences and Varex Imaging Corp is 0.29 (i.e., Modest diversification). The correlation of Cytek Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cytek Biosciences Correlation With Market

Average diversification

The correlation between Cytek Biosciences and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytek Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.

Moving against Cytek Stock

  0.44TFX Teleflex IncorporatedPairCorr
  0.39ATMV ATMV Old Symbol ChangePairCorr
  0.32MMC MMC Old Symbol ChangePairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TMCICLPT
CBLLLAB
KIDSCBLL
AVNSVREX
ANGOORGO
KIDSLAB
  

High negative correlations

ANGOVREX
CBLLTMCI
ORGOVREX
CBLLCLPT
ANGOAVNS
TMCILAB

Risk-Adjusted Indicators

There is a big difference between Cytek Stock performing well and Cytek Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cytek Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
VREX  1.63  0.25  0.07  0.92  3.09 
 3.76 
 17.42 
AVNS  1.66  0.18  0.09  0.22  1.79 
 4.68 
 9.85 
LAB  3.05  0.34  0.07 (0.16) 3.20 
 7.81 
 24.04 
CLPT  3.44 (0.57) 0.00 (0.36) 0.00 
 7.36 
 21.07 
TMCI  3.45 (1.55) 0.00 (1.39) 0.00 
 5.60 
 28.25 
SRDX  4.75  2.55  0.00  13.03  0.00 
 2.93 
 49.69 
CBLL  2.58  1.02  0.39 (18.46) 1.84 
 6.82 
 18.00 
KIDS  1.88  0.13  0.04 (0.35) 2.15 
 3.72 
 16.89 
ORGO  3.65  0.24  0.04 (0.18) 3.63 
 9.18 
 55.15 
ANGO  2.11 (0.16) 0.00  0.31  0.00 
 4.34 
 18.26 

Cytek Biosciences Corporate Management

Todd GarlandChief OfficerProfile
Ming YanCTO DirectorProfile
Melik UlusuSenior ChainProfile
Mark EdingerVP AffairsProfile
Allen PoirsonSenior DevelopmentProfile
Connie WedelChief OfficerProfile